RNA

An Efficient Approach based on Multi-sources Information to Predict CircRNA-disease Associations Using Deep Convoltional Neural Network

8 days ago   |   By Oxford Journals

AbstractMotivationEmerging evidence indicates that circular RNA plays a crucial role in human disease. Using circRNA as biomarker gives rise to a new perspective regarding our diagnosing of diseases and understanding of disease pathogenesis. However, detection of circRNA-disease associations by biological experiments alone is often blind, limited to small-scale, high-cost and time-consuming. Therefore, there is an urgent need for reliable computational methods to rapidly infer the potential circRNA-disease associations on a large scale and to provide the most promising candidates for...
Read more ...

 

MiR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes

8 days ago   |   By Springer

Abstract
Aims/hypothesis
MicroRNAs are a novel class of potential biomarkers emerging in many diseases, including type 1 diabetes. Here, we aim to analyse a panel of circulating miRNAs in non-obese diabetic mice and individuals with type 1 diabetes.
Methods
We adopted standardised methodologies for extracting miRNAs from small sample volumes to evaluate a profiling panel of mature miRNAs in paired plasma and laser-captured microdissected immune-infiltrated islets of recently diabetic and normoglycaemic NOD mice. Moreover, we validated the findings during disease progression and remission...
Read more ...

 

An improved random forest-based computational model for predicting novel miRNA-disease associations

8 days ago   |   By Springer

Abstract
Background
A large body of evidence shows that miRNA regulates the expression of its target genes at post-transcriptional level and the dysregulation of miRNA is related to many complex human diseases. Accurately discovering disease-related miRNAs is conductive to the exploring of the pathogenesis and treatment of diseases. However, because of the limitation of time-consuming and expensive experimental methods, predicting miRNA-disease associations by computational models has become a more economical and effective mean.
Results
Inspired by the work of predecessors, we proposed an...
Read more ...

 

A novel target convergence set based random walk with restart for prediction of potential LncRNA-disease associations

8 days ago   |   By Springer

Abstract
Background
In recent years, lncRNAs have been proved to be closely related to the occurrence and development of many serious diseases that are seriously harmful to human health. However, most of the lncRNA-disease associations have not been found yet due to high costs and time complexity of traditional bio-experiments. Hence, it is quite urgent and necessary to establish efficient and reasonable computational models to predict potential associations between lncRNAs and diseases.
Results
In this manuscript, a novel prediction model called TCSRWRLD is proposed to predict potential...
Read more ...

 


Search by Tags

   RNA      Biology      Biologic      Biological      Computers      Paper      Therapies      Obesity      Immunity      Gene      Genes      Human health      Health  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

How Thermo Fisher Scientific Streamlined Inspection Management With AuditUtopia®

How Thermo Fisher Scientific Streamlined Inspection Management With AuditUtopia®

Case Study Overview In highly regulated industries, you can count on the fact that your company will be inspected a time or two by regulatory agencies and/or your clients. Most... Read more ...

Cover Picture: Biotechnology Journal 12/2019

Cover Picture: Biotechnology Journal 12/2019

Microbial poly‐3‐hydroxybutyrate has been produced via microbial fermentation and safely used as feed additives for sea based large yellow croakers and sensitive land based... Read more ...

A Peek into the Battery Technology Pipeline

A Peek into the Battery Technology Pipeline

Berkeley Lab battery researcher Gerbrand Ceder Lithium ion is probably the most advanced technology available for the packs of rechargeable batteries you'll buy this holiday... Read more ...

Long-Read Sequencing Could Improve the Sensitivity and Precision of 16S...

Long-Read Sequencing Could Improve the Sensitivity and Precision of 16S Sequencing Says Jackson Lab Study

It's time to revisit the way scientists are using 16S rRNA gene sequencing to study microorganisms, according to a team of Jackson Laboratory researchers. Popular targets for... Read more ...

Iterum's Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink

Iterum's Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink

Iterum Therapeutics' bid to bring patients a new antibiotic that's safer than currently available drugs has fallen short of the main efficacy goal of a late-stage clinical... Read more ...

Flagship's Cellarity Aims to Advance Cell Behavior-Based Therapeutics

Flagship's Cellarity Aims to Advance Cell Behavior-Based Therapeutics

The latest startup to emerge from Flagship Pioneering aims to change drug discovery by starting the process with a clear understanding of cell behavior. Cellarity-like many... Read more ...

KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test

KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test

A KalVista Pharmaceuticals eye drug at the center of a research collaboration with Merck has failed a mid-stage clinical trial. KalVista developed its drug, KVD001, to treat... Read more ...

Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules

Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules

Zentalis Pharmaceuticals is banking on small molecules for cancer-leaving the “cool technologies” aside for a “tried and true” approach, says the CEO, who wants to let the... Read more ...

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

The Scripps Research Institute and AbbVie have agreed to broaden an existing drug discovery agreement focused on cancer cell therapies to now encompass treatments for other... Read more ...

From Hawaii to PECASE award: tips of success from a female bioinformatician

Read more ...